Action Intelligent Bio Solutions - INBS

Intelligent Bio Solutions Inc (INBS) Action

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

2,40

( -2,44% )

Prix Achat

1,86

Prix Vente

2,60

Volume échangé

115 787

2,24 Fourchette du Jour 2,45

0,538 Plage de 52 semaines 24,90

Cap du marché

5,74M

Clôture Veille

2,46

Ouverture

2,43

Dernière Transaction

2.4

Dernière heure de transaction

Volume financier

US$ 275 581

VWAP

2,3801

Volume moyen (3 m)

US$ 119 207

Actions en circulation

2 391 846

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-0,23

Bénéfice par action (BPA)

-11,34

Chiffre d'affairess (LTM)

3,91M

Bénéfice net (LTM)

-11,61M

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platf... Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York. Show more

Secteur

Healthcare

Industrie

Medical Equipment & Supplies

Site Web

ibs.inc

Siège social

New York, United States

Fondé

2026

Intelligent Bio Solutions Inc est coté dans le secteur Healthcare de la NASDAQ avec le ticker INBS. Le dernier cours de clôture d'Intelligent Bio Solutions était de US$2,46. Au cours de la dernière année, les actions de Intelligent Bio Solutions ont été négociées dans une fourchette de prix de US$ 0,538 à US$ 24,90.

Intelligent Bio Solutions compte actuellement 2 391 846 actions en circulation. La capitalisation boursière d'Intelligent Bio Solutions est de US$5,74 million. Intelligent Bio Solutions a un ratio cours/bénéfice (ratio PE) de -0.23.

Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18

NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the...

Form 8-K - Current report

Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission

Study designed to validate accuracy and real-world workplace performance of the Intelligent Fingerprinting Drug...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year

Razor-razorblade business model accelerates, with Q3 cartridge revenue up 59% year-over-year, representing 66...

Form 8-K - Current report

Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified

NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the...

Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market

Study results finalized on schedule support FDA clearance and planned U.S. commercial launch Company advances...

Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant

NEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.09	-3.61445783133	2.49	2.63	2.4	59124	2.49297082	CS
4	0.06	2.5641025641	2.34	5.2	2.29	199299	3.33806582	CS
12	-1.69	-41.3202933985	4.09	5.2	2.27	124821	3.10726451	CS
26	1.65	220	0.75	24.9	0.538	1263763	9.61951863	CS
52	0.83	52.8662420382	1.57	24.9	0.538	744212	8.28639606	CS
156	-0.65	-21.3114754098	3.05	24.9	0.19	1408541	3.10870971	CS
260	1.9051	384.946453829	0.4949	24.9	0.17	1406037	2.77854084	CS

INBS - Frequently Asked Questions (FAQ)

What is the current Intelligent Bio Solutions Inc share price?

The current share price of Intelligent Bio Solutions Inc is US$ 2,40

How many Intelligent Bio Solutions Inc shares are in issue?

Intelligent Bio Solutions Inc has 2 391 846 shares in issue

What is the market cap of Intelligent Bio Solutions Inc?

The market capitalisation of Intelligent Bio Solutions Inc is USD 5,74M

What is the 1 year trading range for Intelligent Bio Solutions Inc share price?

Intelligent Bio Solutions Inc has traded in the range of US$ 0,538 to US$ 24,90 during the past year

What is the PE ratio of Intelligent Bio Solutions Inc?

The price to earnings ratio of Intelligent Bio Solutions Inc is -0,23

What is the cash to sales ratio of Intelligent Bio Solutions Inc?

The cash to sales ratio of Intelligent Bio Solutions Inc is 1,57

What is the registered address of Intelligent Bio Solutions Inc?

The registered address for Intelligent Bio Solutions Inc is 135 West, 41st Street, New York, New York, 10036

What is the Intelligent Bio Solutions Inc website address?

The website address for Intelligent Bio Solutions Inc is ibs.inc

Which industry sector does Intelligent Bio Solutions Inc operate in?

Intelligent Bio Solutions Inc operates in the Medical Equipment & Supplies sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Intelligent Bio Solutions Inc (INBS)

Intelligent Bio Solutions Inc (INBS) Action

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

À propos de Intelligent Bio Solutions Inc

INBS Dernières nouvelles

Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18

Form 8-K - Current report

Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year

Form 8-K - Current report

Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified

Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market

Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant

Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18

Form 8-K - Current report

Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year

Form 8-K - Current report

Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified

Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market

Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

INBS - Frequently Asked Questions (FAQ)

INBS Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Pourquoi rejoindre ADVFN?

Tout ce dont les traders professionnels ont besoin.

Supprimer les publicités